Table 1.
Study | Country setting | Chronic illness | Aim of studies | Methods | Study population | Outcomes |
||
---|---|---|---|---|---|---|---|---|
User satisfaction | Health related measures | Patient safety | ||||||
Al-Hilli et al. [26] | USA | Breast cancer | Education | RCT | IG = 19; CG = 18; women with stage 0–III breast cancer | No significant difference in median satisfaction score between Chatbot and traditional counseling (30 vs. 30, p = .19) | Not reported | Not reported |
Bibault et al. [27] | France | Breast cancer | Self-management | RCT | The study included female subjects aged 18 years or older who were either undergoing treatment for breast cancer or in remission. These participants demonstrated nonopposition and possessed internet literacy. | The findings indicate that among the patients, 59% expressed a desire for more information compared to 65% in the control group. In the study, 85% of the patients reported finding the information provided by the chatbot to be valuable, and the same percentage expressed satisfaction with the quantity of information received. This stands in contrast to the control group, where 83.1% and 77% reported similar levels of usefulness and satisfaction, respectively. Moreover, when comparing the ratings of chatbot responses to those provided by physicians in real-time, patients rated the chatbot responses more favourably. Overall, the study demonstrated noninferiority in the perceived quality of responses between the chatbot and physician-provided responses. | Not reported | The research exhibits a deficiency in transparent reporting concerning various facets of adverse events. These include the absence of specific data on the quantity of adverse events communicated through the electronic clinical assistant (ECA) and directly to the clinic by the patient, the duration taken to identify and rectify adverse events, as well as the rate of false alarms associated with adverse events reported through the ECA and directly to the clinic by the patient. |
Echeazarra et al. [28] | Spain | Hypertension | Self-management | RCT | Individuals experiencing elevated blood pressure Total = 112; intervention group (IG) = 55; control group (CG) = 57 |
The participants gave the bot a highly favourable rating, found it to be valuable and user-friendly, and maintained its use even after the intervention period. | The bot group demonstrated comparable adherence to the blood pressure check schedule (bot group mean = 12.0, control group mean = 13.4, p = .109). Additionally, the intervention group (IG) significantly enhanced knowledge of proper blood pressure self-monitoring practices compared to the control group (CG) (IG mean = 24.126, CG mean = 17.591, p = .03737). | Not reported |
Gong et al. [29] | Australia | Type 2 diabetes mellitus | Self-management | RCT | Adult with type 2 diabetes mellitus, N = 187; IG = 93; CG = 94 | 92 samples (98.9%) engaged in at least one chat with chatbot, and 83 participants (89.2%) uploaded their blood glucose levels to the app at least once. These 92 participants had a combined total of 1942 chats over the 12-month program, averaging 243 min per person (SD = 212). | At 12 months, there was a notable difference between the two groups: quality of life (difference: 0.04, 95% CI [0.00, 0.07]; p = .04), not in HbA1c levels. In comparison to baseline, both groups experienced a reduction in mean estimated HbA1c levels at 12 months (IG: mean estimated change: −0.33%; p = .03 and control arm: −0.28%; p = .05). | Not reported |
Greer et al. [14] | USA | Post cancer treatment | After cancer treatment | Pilot RCT | The research encompassed a cohort of 45 young adults, segregated into two distinct groups. Group 1, constituting 25 young adults, was designated as the experimental cohort, while group 2, comprising 20 young adults, functioned as the control cohort. At the outset, all participants underwent a comprehensive survey assessment. | Their assessments indicated a positive reception, with an average rating of 2.0 out of 3 (SD 0.72) for perceived helpfulness, and an expressed likelihood to recommend it to others, with a mean score of 6.9 out of 10 (SD 2.6). | The intervention group showed an average anxiety reduction of 2.58 standardized t-score units. Results showed a nearly significant group–time interaction (p = .09), resulting in an effect size of 0.41. Additionally, the IG experienced greater anxiety reduction with more frequent engagement sessions (p = .06). However, there were no significant differences between the groups in terms of changes in depression, positive or negative emotion. | Not reported |
Hauser-Ulrich et al. [30] | Germany and Switzerland | Chronic pain | Self-management of chronic pain | Pilot RCT | The study involved 102 participants recruited from the SELMA app. Their average age was 43.7 years. Of these, 14 were male and 88 were female. The duration of their participation in the study spanned two months. | Acceptance: 63% of users found the app fun, 47% found it useful, and 84% found it easy to use among 38 respondents. Adherence: the regular adherence percentage was 71% for 200 conversations initiated on Instagram. |
There was a significant positive intention to alter behaviour concerning impairment and pain intensity (p = .01). There was no statistically significant alteration in pain-related impairment (p = .01) observed in the IG compared CG. |
Not reported |
Hunt et al. [31] | USA | Irritable bowel syndrome (IBS) | Education and self-management | RCT | 121 adult with IBS, IG = 62, CG = 59 | Completion rate 94% | Immediate treatment group improved significantly compared to wait-list CG in: Gastrointestinal symptom severity (Cohen’s d = 1.02, p < .001) QoL (Cohen’s d = 1.25, p < .001) GI-specific catastrophizing (Cohen’s d = 1.47, p < .001) Fear of food (Cohen’s d = 0.62, p = .001) Visceral anxiety (Cohen’s d = 1.07, p < .001) Depression (Cohen’s d = 1.07, p = .002) However, anxiety did not show a significant result for the IG. |
Not reported |
Tawfik et al. [32] | Egypt | Breast cancer | Education, self-management | RCT | 150 participants (50 per group), aged 20+, recently diagnosed with early-stage non-metastatic breast cancer (stage 0–III), scheduled for first or second chemotherapy, able to read/write, and own a smartphone. | Easy to use: 94% Useful and informative responses: 94% Understanding: 72% Welcoming setup: 88% Women find it navigable: 70% Realistic and engaging personality: 72% Some reported mistakes: 76% |
Participants showed significantly fewer, milder and less distressing symptoms, along with better self-care (p > .001), compared to nurse-led education and routine care groups. | Not reported |